Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Coupling endonucleases with DNA end–processing enzymes to drive gene disruption

Nature Methods volume 9, pages 973–975 (2012)Cite this article

Subjects

Abstract

Targeted DNA double-strand breaks introduced by rare-cleaving designer endonucleases can be harnessed for gene disruption applications by engaging mutagenic nonhomologous end-joining DNA repair pathways. However, endonuclease-mediated DNA breaks are often subject to precise repair, which limits the efficiency of targeted genome editing. To address this issue, we coupled designer endonucleases to DNA end–processing enzymes to drive mutagenic break resolution, achieving up to 25-fold enhancements in gene disruption rates.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Coupling endonucleases to exonucleases increases gene disruption.
Figure 2: DNA end–processing enzymes library screen.
Figure 3: Trex2 increases knockout of endogenous CCR5 with an engineered homing endonuclease.

Similar content being viewed by others

References

  1. Urnov, F.D., Rebar, E.J., Holmes, M.C., Zhang, H.S. & Gregory, P.D. Nat. Rev. Genet. 11, 636–646 (2010).

    Article  CAS  Google Scholar 

  2. Lieber, M.R. Annu. Rev. Biochem. 79, 181–211 (2010).

    Article  CAS  Google Scholar 

  3. McVey, M. & Lee, S.E. Trends Genet. 24, 529–538 (2008).

    Article  CAS  Google Scholar 

  4. Mladenov, E. & Iliakis, G. Mutat. Res. 711, 61–72 (2011).

    Article  CAS  Google Scholar 

  5. Shrivastav, M., De Haro, L.P. & Nickoloff, J.A. Cell Res. 18, 134–147 (2008).

    Article  CAS  Google Scholar 

  6. Bennardo, N., Gunn, A., Cheng, A., Hasty, P. & Stark, J.M. PLoS Genet. 5, e1000683 (2009).

    Article  Google Scholar 

  7. Szymczak, A.L. & Vignali, D.A.A. Expert Opin. Biol. Ther. 5, 627–638 (2005).

    Article  CAS  Google Scholar 

  8. Certo, M.T. et al. Nat. Methods 8, 671–676 (2011).

    Article  CAS  Google Scholar 

  9. Maeder, M.L., Thibodeau-Beganny, S., Sander, J.D., Voytas, D.F. & Joung, J.K. Nat. Protoc. 4, 1471–1501 (2009).

    Article  CAS  Google Scholar 

  10. Miller, J.C. et al. Nat. Biotechnol. 29, 143–148 (2011).

    Article  CAS  Google Scholar 

  11. Cannon, P. & June, C. Curr. Opin. HIV AIDS 6, 74–79 (2011).

    Article  Google Scholar 

  12. Smith, J. et al. Nucleic Acids Res. 34, e149 (2006).

    Article  Google Scholar 

  13. Pattanayak, V., Ramirez, C.L., Joung, J.K. & Liu, D.R. Nat. Methods 8, 765–770 (2011).

    Article  CAS  Google Scholar 

  14. Sather, B.D. et al. Mol. Ther. 19, 515–525 (2011).

    Article  CAS  Google Scholar 

  15. Cermak, T. et al. Nucleic Acids Res. 39, e82 (2011).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

M.T.C. was supported in part by the US Public Health Service and National Research Service Award (T32 GM07270) from the US National Institute of General Medical Sciences. Additional funding was from the US National Institutes of Health (RL1CA133832, UL1DE019582, R01-HL075453, PL1-HL092557, RL1-HL092553, RL1-HL92554 and U19-AI96111) and Seattle Children's Center for Immunity and Immunotherapies. We would like to thank J. Stark (Beckman Research Institute and City of Hope) and D. Stetson (University of Washington) for initial Trex2 expression plasmids and D. Voytas (University of Minnesota) for TALEN cloning reagents. Zinc-finger nuclease expression plasmids were provided by C. Ramirez and K. Joung (Harvard University and Massachusetts General Hospital). J. Jarjour (Seattle Children's Research Institute, presently Pregenen Inc.) designed the Sce-SCID mouse, and Sce-SCID MEFs were provided by A. Astrakhan and G. Metzler (University of Washington). We thank all members of the Northwest Genome Editing Consortium for their many insightful discussions.

Author information

Author notes

  1. Michael T Certo and Kamila S Gwiazda: These authors contributed equally to this work.

Authors and Affiliations

  1. Molecular and Cellular Biology Program, University of Washington, Seattle, Washington, USA

    Michael T Certo, Kamila S Gwiazda & Kyle Jacoby

  2. Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Washington, USA

    Michael T Certo, Kamila S Gwiazda, Ryan Kuhar, Blythe Sather, Gabrielle Curinga, Tyler Mandt, Michelle Brault, Abigail R Lambert, Sarah K Baxter, Kyle Jacoby, Byoung Y Ryu, David J Rawlings & Andrew M Scharenberg

  3. Department of Immunology, University of Washington, Seattle, Washington, USA

    Sarah K Baxter, David J Rawlings & Andrew M Scharenberg

  4. Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

    Hans-Peter Kiem

  5. Department of Medicine, University of Washington, Seattle, Washington, USA

    Hans-Peter Kiem

  6. Department of Pathology, University of Washington, Seattle, Washington, USA

    Hans-Peter Kiem

  7. Cellectis, Paris, France

    Agnes Gouble, Frederic Paques & Andrew M Scharenberg

  8. Department of Pediatrics, University of Washington, Seattle, Washington, USA

    David J Rawlings & Andrew M Scharenberg

Authors
  1. Michael T Certo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kamila S Gwiazda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ryan Kuhar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Blythe Sather
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gabrielle Curinga
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tyler Mandt
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michelle Brault
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Abigail R Lambert
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sarah K Baxter
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kyle Jacoby
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Byoung Y Ryu
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Hans-Peter Kiem
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Agnes Gouble
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Frederic Paques
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. David J Rawlings
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Andrew M Scharenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M.T.C. designed and conceived experiments. M.T.C., K.S.G., R.K., B.S., G.C., M.B. and T.M. performed experiments. A.R.L., S.K.B., K.J., M.B., B.Y.R., H.-P.K., A.G. and F.P. provided reagents. M.T.C. wrote the paper and K.S.G., D.J.R. and A.M.S. edited the paper. D.J.R. and A.M.S provided technical support and conceptual advice.

Corresponding authors

Correspondence to David J Rawlings or Andrew M Scharenberg.

Ethics declarations

Competing interests

A.M.S., F.P. and A.G. are employees of Cellectis and receive salary and equity compensation. A.M.S. is cofounder and board member of Pregenen Inc., a genome engineering company. A provisional patent (no. 61/447,672) for coupling endonucleases with exonucleases for gene disruption has been filed by Seattle Children's Research Institute.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–10, Supplementary Tables 1 and 2 and Supplementary Note 1 (PDF 1352 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Certo, M., Gwiazda, K., Kuhar, R. et al. Coupling endonucleases with DNA end–processing enzymes to drive gene disruption. Nat Methods 9, 973–975 (2012). https://doi.org/10.1038/nmeth.2177

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nmeth.2177

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing